Literature DB >> 3534615

[Pharmacokinetics of anti-hypertensive drugs in renal failure].

T Hannedouche, J P Fillastre.   

Abstract

Anti-hypertensive drugs which are mainly eliminated by the kidney can accumulate in renal failure. Posology of hydrosoluble beta-blockers, converting enzyme inhibitors and central anti-hypertensive drugs should therefore be reduced. Anti-hypertensive drugs whose metabolism is predominantly or exclusively hepatic, such as liposoluble beta-blockers, calcium antagonists and prazosin, can be used at usual posologies. At end-stage renal failure posology of diuretics may have to be increased in order to attain a pharmacodynamic effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534615

Source DB:  PubMed          Journal:  Nephrologie        ISSN: 0250-4960


  1 in total

1.  Pharmacokinetics and safety of cicloprolol in uraemic patients.

Authors:  J P Fillastre; M Aparicio; C Porquet; C Dubruc; P Rosenzweig; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.